Skip to content

Appetite Regulation in Children With Failure to Thrive

Appetite-regulating Hormones, the Gut Microbiome and the Metabolome in Children With Failure to Thrive

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02647580
Enrollment
45
Registered
2016-01-06
Start date
2015-12-31
Completion date
2017-06-30
Last updated
2017-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failure to Thrive

Keywords

Growth, Children, Appetite-regulating hormones, Gut Microbiota

Brief summary

Failure to thrive (FTT) is an expression for inadequate growth in the early childhood and thus, a sign of undernutrition. This study will include children with FTT, and compare with existing data from children with normal and excessive growth. The overall aim of this study is to explore whether 1) children who develop FTT with no organic explanation differ from healthy normal weight and overweight children in their basal level of appetite-regulating hormones and 2) if inadequate, normal and excessive growth in children can be partly predicted by variation in their gut microbiome and metabolome.

Interventions

None listed

Sponsors

Hvidovre University Hospital
CollaboratorOTHER
Technical University of Denmark
CollaboratorOTHER
Lena Kirchner Brahe
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Months to 36 Months
Healthy volunteers
No

Inclusion criteria

* Diagnosed with failure to thrive * Weight for height \> 1.9 SD below the median by use of the WHO Child Growth Standards * Age between 12-36 months

Exclusion criteria

* Cancer * Inflammatory bowel disease * Celiac disease * Immunodeficiency * Other somatic disease that can explain the growth failure

Design outcomes

Primary

MeasureTime frame
Appetite-regulating hormones (ghrelin, PYY, leptin) measured by fasting blood samplesAt subject enrollment

Secondary

MeasureTime frame
Metabolome measured by urine samplesAt subject enrollment
Metabolic markers (insulin, glucose) measured by fasting blood samplesAt subject enrollment
Body weight measured in kilogramsAt subject enrollment
Microbiota composition measured by fecal samplesAt subject enrollment
Head circumference measured in centimetersAt subject enrollment
Waist circumference measured in centimetersAt subject enrollment
Height measured in centimetersAt subject enrollment

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026